OCULEX PHARMACEUTICALS
Oculex Pharmaceuticals is an ophthalmic drug delivery company that is focused on the development of therapeutic products for the treatment of sight-threatening diseases. Oculex Pharmaceuticals develops Posurdex, a biodegradable release implant that delivers dexamethasone to the targeted disease site at the back of the eye. Oculex Pharmaceuticals was acquired by Allergan in November 2003. Oculex Pharmaceuticals was founded in 1989 and is based in Sunnyvale, California.
OCULEX PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1989-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.oculex.com
Total Employee:
101+
Status:
Active
Total Funding:
50 M USD
Similar Organizations
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Xenon Pharmaceuticals
Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.
Current Advisors List
Investors List
Vivo Capital
Vivo Capital investment in Series B - Oculex Pharmaceuticals
Bay City Capital
Bay City Capital investment in Series B - Oculex Pharmaceuticals
Venture TDF
Venture TDF investment in Series B - Oculex Pharmaceuticals
Perseus-Soros Biopharmaceutical Fund
Perseus-Soros Biopharmaceutical Fund investment in Series B - Oculex Pharmaceuticals
Aisling Capital
Aisling Capital investment in Series B - Oculex Pharmaceuticals
GGV Capital
GGV Capital investment in Series B - Oculex Pharmaceuticals
Official Site Inspections
http://www.oculex.com
- Host name: 204.74.99.105
- IP address: 204.74.99.105
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
